SCHEMBL6606922

SCHEMBL6606922

CN(C)CC#Cc1ccncc1NC(=O)OC(C)(C)C.CN(C)CCCc1ccncc1N

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D P28221 3/20 0.33
HTR1B P28222 3/20 0.33
NAMPT P43490 2/20 0.33
CYP17A1 P05093 1/20 0.32
ATR Q13535 1/20 0.32
CYP3A4 P08684 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP1A2 P05177 1/20 0.32
HTR1A P08908 1/20 0.32
CYP2D6 P10635 1/20 0.32
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32
CYP2C19 P33261 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
HCK P08631 1/20 0.31
MAPK12 P53778 1/20 0.31
MAPK14 Q16539 1/20 0.31
PDE5A O76074 1/20 0.31
PDE4A P27815 1/20 0.31
PDE1A P54750 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6035878 0.86 NAMPT (0.41) HTR1DHTR1BNAMPTCYP17A1CYP3A4
SCHEMBL6607970 0.81 NAMPT (0.38) HTR1DHTR1BNAMPTCYP17A1CYP3A4
SCHEMBL6034096 0.71 CYP2A6 (0.44) HTR1DHTR1BCYP3A4ALDH1A1CYP1A2
SCHEMBL6034703 0.71 AOC1 (0.52) HTR1DHTR1BCYP3A4ALDH1A1CYP1A2
SCHEMBL6034950 0.70 CYP17A1 (0.44) NAMPTCYP17A1ATRCYP3A4KCNQ4
SCHEMBL17347511 0.70 CYP17A1 (0.37) NAMPTCYP17A1CYP3A4
SCHEMBL18848179 0.69 ALDH1A1 (0.41) NAMPTCYP17A1CYP3A4ALDH1A1
SCHEMBL6627397 0.69 ACHE (0.39) CYP17A1ALDH1A1PDE5APDE4APDE1A
SCHEMBL5746021 0.69 NAMPT (0.47) NAMPTCYP17A1ALDH1A1
SCHEMBL28390904 0.69 NAMPT (0.47) NAMPTCYP17A1ATRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414801-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 AstraZeneca AB (SE) 2004-05-06 EP disclosed
WO-2003004472-A1 ARYLAMINES FOR THE TREATMENT OF CONDITIONS ASSOCIATED WITH GSK-3 ASTRAZENECA AB (SE) 2003-01-16 WO disclosed